Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Trust iShares Russell 2000 BuyWrite ETF (NY:IWMW)

41.29 +0.19 (+0.46%)
Streaming Delayed Price Updated: 3:35 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Trust iShares Russell 2000 BuyWrite ETF

< Previous 1 2 3 Next >
Teladoc Stock Shot Up 8% Today: BofA Views It As Differentiated Asset But Remains Cautious On Near-Term Outlook
BofA’s new price target represents a potential upside of about 5% from the stock’s closing price on Thursday. 
Via Stocktwits
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy
CEO Barbara Weber said that across the 16 cancer types enrolled in the trial, the objective response rate (ORR) was 27% in patients with a median follow-up of 9.4 months. 
Via Stocktwits
DNUT Stock Trades Above 200-DMA For The First Time Since November 2024
Morgan Stanley kept its ‘Underweight’ rating and $2.5 price target on Krispy Kreme. 
Via Stocktwits
Topics ETFs
Beyond Meat Stock Skyrockets 60% Today: Meme Stock Frenzy Intensifies After ETF Inclusion Amid Surging Retail Buzz
Roundhill Investments said that Beyond Meat has been added to the Roundhill Meme Stock ETF. 
Via Stocktwits
Topics Artificial Intelligence ETFs
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors?
Via Stocktwits
Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds
Via Stocktwits
Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report
Via Stocktwits
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process
Via Stocktwits
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing. 
Via Stocktwits
Applied Digital Stock Soars 7% Pre-Market On $5B AI Factory Lease With US Hyperscaler
Applied Digital said that this was a nearly 15-year lease agreement to deliver 200 MW of critical IT capacity at Polaris Forge 2. 
Via Stocktwits
Topics Artificial Intelligence
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm
BofA analyst Alexander Perry raised the firm's price target on Polaris to $70 from $60 after the company agreed to sell a majority stake in Indian Motorcycle to California-headquartered private equity... 
Via Stocktwits
Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity
Shah Capital currently owns 11.8 million shares or 7.2% of Novavax. 
Via Stocktwits
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment
SELLAS said that in a study model, SLS009 monotherapy and the combination prolonged overall survival compared to Venetoclax alone, with a statistically significant difference. 
Via Stocktwits
Plug Power Names Insider Jose Luis Crespo As New CEO
Via Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals
Via Stocktwits
Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs
Via Stocktwits
Topics Intellectual Property
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy
The company said that the decision is based on business and strategic considerations and does not reflect concerns regarding the safety or efficacy profile of Fanskya. 
Via Stocktwits
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy
Taysha also announced that it has finalized alignment with the FDA on the protocol for the trial intended to support its application for approval of TSHA-102. 
Via Stocktwits
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
The company said on Wednesday that its drug did not meet the primary endpoint of the trial primarily due to a higher-than-expected placebo response rate. 
Via Stocktwits
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026. 
Via Stocktwits
AMC Entertainment Stock Is Rising Today And There’s A Taylor Swift Angle – Find Out More
Via Stocktwits
Oklo Stock Continues To Be The Talk Of The Town After Gaining 87% In A Month – Here’s How Retail Investors Responded
Via Stocktwits
This Stock Nearly Doubled In A Month, And It Just Received A Fresh Price Target Hike By Roth Capital – Find Out More
Via Stocktwits
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
The order encompasses multiple product offerings within Emergent’s medical countermeasures business, including countermeasures for threats posed by Smallpox, Anthrax, and Botulism. 
Via Stocktwits
Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details
Via Stocktwits
Replimune Stock Plunged 42% Today – Here’s Why
Via Stocktwits
Cracker Barrel In Spotlight After Slew Of Price Target Cuts: Citi Says Q1 Began In A ‘Deep Traffic Hole’ Post Logo Change
Via Stocktwits
Krispy Kreme Stock Pops After FBI Director Kash Patel Reportedly Endorses It As A ‘Good Investment’: Retail Chatter Soars Over 600%
Via Stocktwits
Why Is New Fortress Energy Stock Rising Today?
The stock gained 23% before the bell on Wednesday after Puerto Rico's Governor Jenniffer Gonzalez announced that the company has reached a new agreement valued at approximately $4 billion to supply LNG... 
Via Stocktwits
Topics Energy
Dave & Buster’s Sees Wall Street Downgrades, Yet Retail Sentiment Red-Hot
UBS said that while Dave & Buster’s was still in the early stages of a turnaround, with macro pressure remaining elevated and visibility limited, an eventual return to consistently positive same-store... 
Via Stocktwits
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.